These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

335 related items for PubMed ID: 15982598

  • 1. Pre-treatment of donor with 1-deamino-8-d-arginine vasopressin could alleviate early failure of porcine xenograft in a cobra venom factor treated canine recipient.
    Kang HJ, Lee G, Kim JY, Lee SH, Wi HC, Hwang PG, Chung DH, Kim YT.
    Eur J Cardiothorac Surg; 2005 Jul; 28(1):149-56. PubMed ID: 15982598
    [Abstract] [Full Text] [Related]

  • 2. Pre-treatment of porcine pulmonary xenograft with desmopressin: a novel strategy to attenuate platelet activation and systemic intravascular coagulation in an ex-vivo model of swine-to-human pulmonary xenotransplantation.
    Kim YT, Lee HJ, Lee SW, Kim JY, Wi HC, Park SJ, Bae SJ, Kang HJ.
    Xenotransplantation; 2008 Feb; 15(1):27-35. PubMed ID: 18333911
    [Abstract] [Full Text] [Related]

  • 3. Complement-mediated pulmonary xenograft injury: studies in swine-to-primate orthotopic single lung transplant models.
    Yeatman M, Daggett CW, Parker W, Byrne GW, Logan JS, Platt JL, Davis RD.
    Transplantation; 1998 Apr 27; 65(8):1084-93. PubMed ID: 9583870
    [Abstract] [Full Text] [Related]

  • 4. Pig to canine auxiliary hepatic xenotransplantation model: prevention of hyperacute rejection via Kupffer cell blockade and complement regulation.
    Chung KY, Park JJ, Han KH.
    Transplant Proc; 2008 Oct 27; 40(8):2755-9. PubMed ID: 18929854
    [Abstract] [Full Text] [Related]

  • 5. Prolongation of cardiac xenograft survival by depletion of complement.
    Leventhal JR, Dalmasso AP, Cromwell JW, Platt JL, Manivel CJ, Bolman RM, Matas AJ.
    Transplantation; 1993 Apr 27; 55(4):857-65; discussion 865-6. PubMed ID: 8475561
    [Abstract] [Full Text] [Related]

  • 6. Complement depletion with cobra venom factor delays acute cell-mediated rejection in pig-to-mouse corneal xenotransplantation.
    Oh JY, Kim MK, Lee HJ, Ko JH, Kim Y, Park CS, Kang HJ, Park CG, Kim SJ, Lee JH, Wee WR.
    Xenotransplantation; 2010 Apr 27; 17(2):140-6. PubMed ID: 20522246
    [Abstract] [Full Text] [Related]

  • 7. [Mechanisms of purified cobra venom factor in preventing hyperacute rejection following discordant liver xenotransplantation in rats].
    Li ZD, Shi CQ, Zhang QH, Xiong YL, Zhou XD, Wang WY, Song N.
    Zhonghua Yi Xue Za Zhi; 2004 Dec 02; 84(23):2007-10. PubMed ID: 15730818
    [Abstract] [Full Text] [Related]

  • 8. Improved suppression of circulating complement does not block acute vascular rejection of pig-to-rhesus monkey cardiac transplants.
    Chen G, Sun QY, Wang XM, Shen SQ, Guo H, Wang H, Wu Y, Wang WY, Xiong YL, Chen S.
    Xenotransplantation; 2004 Mar 02; 11(2):123-32. PubMed ID: 14962274
    [Abstract] [Full Text] [Related]

  • 9. Aurintricarboxylic acid inhibits endothelial activation, complement activation, and von Willebrand factor secretion in vitro and attenuates hyperacute rejection in an ex vivo model of pig-to-human pulmonary xenotransplantation.
    Kim HK, Kim JE, Wi HC, Lee SW, Kim JY, Kang HJ, Kim YT.
    Xenotransplantation; 2008 Mar 02; 15(4):246-56. PubMed ID: 18957047
    [Abstract] [Full Text] [Related]

  • 10. Accommodation after lung xenografting from hamster to rat.
    Tabata T, de Perrot M, Keshavjee S, Liu M, Downey GP, Waddell TK.
    Transplantation; 2003 Mar 15; 75(5):607-12. PubMed ID: 12640297
    [Abstract] [Full Text] [Related]

  • 11. [Effect of Yunnan-cobra venom factor in overcoming acute humoral rejection after allograft cardiac transplantation in presensitized recipients: experiment with rats].
    Li R, Chen G, Guo H, Wang DW, Xie L, Wang SS, Wang WY, Xiong YL, Chen S.
    Zhonghua Yi Xue Za Zhi; 2006 Jun 06; 86(21):1460-3. PubMed ID: 16842697
    [Abstract] [Full Text] [Related]

  • 12. Complement-fixing elicited antibodies are a major component in the pathogenesis of xenograft rejection.
    Miyatake T, Sato K, Takigami K, Koyamada N, Hancock WW, Bazin H, Latinne D, Bach FH, Soares MP.
    J Immunol; 1998 Apr 15; 160(8):4114-23. PubMed ID: 9558123
    [Abstract] [Full Text] [Related]

  • 13. Platelet sequestration and activation during GalTKO.hCD46 pig lung perfusion by human blood is primarily mediated by GPIb, GPIIb/IIIa, and von Willebrand Factor.
    Burdorf L, Riner A, Rybak E, Salles II, De Meyer SF, Shah A, Quinn KJ, Harris D, Zhang T, Parsell D, Ali F, Schwartz E, Kang E, Cheng X, Sievert E, Zhao Y, Braileanu G, Phelps CJ, Ayares DL, Deckmyn H, Pierson RN, Azimzadeh AM, Dandro A, Karavi K.
    Xenotransplantation; 2016 May 15; 23(3):222-236. PubMed ID: 27188532
    [Abstract] [Full Text] [Related]

  • 14. Effect of an anti-C5a monoclonal antibody indicates a prominent role for anaphylatoxin in pulmonary xenograft dysfunction.
    Gaca JG, Appel JZ, Lukes JG, Gonzalez-Stawinski GV, Lesher A, Palestrant D, Logan JS, Love SD, Holzknecht ZE, Platt JL, Parker W, Davis RD.
    Transplantation; 2006 Jun 27; 81(12):1686-94. PubMed ID: 16794535
    [Abstract] [Full Text] [Related]

  • 15. Synergistic suppression of pre-perfusion of donor livers with recipient serum and cobra venom factor treatment on hyperacute rejection following liver xenotransplantation.
    Zhu B, Tong C, Guo W, Pu R, Zhang G, Wang L, Li M.
    Acta Cir Bras; 2012 May 27; 27(5):301-5. PubMed ID: 22666742
    [Abstract] [Full Text] [Related]

  • 16. Effects of two types of cobra venom factor on porcine complement activation and pulmonary artery pressure.
    Cheung AK, Parker CJ, Wilcox L.
    Clin Exp Immunol; 1989 Nov 27; 78(2):299-306. PubMed ID: 12412765
    [Abstract] [Full Text] [Related]

  • 17. Pathogenesis and pathology of delayed xenograft rejection in pig-to-rhesus monkey cardiac transplantation.
    Chen D, Cao R, Guo H, Chen G, Wang X, Shen S, Chen S.
    Transplant Proc; 2004 Oct 27; 36(8):2480-2. PubMed ID: 15561288
    [Abstract] [Full Text] [Related]

  • 18. Delayed xenograft rejection in C3-depleted discordant (pig-to-baboon) cardiac xenografts treated with cobra venom factor.
    Kobayashi T, Taniguchi S, Ye Y, Niekrasz M, Kosanke S, Neethling FA, Wright LJ, Rose AG, White DJ, Cooper DK.
    Transplant Proc; 1996 Apr 27; 28(2):560. PubMed ID: 8623270
    [No Abstract] [Full Text] [Related]

  • 19. Effect of repetitive high-dose treatment with soluble complement receptor type 1 and cobra venom factor on discordant xenograft survival.
    Candinas D, Lesnikoski BA, Robson SC, Miyatake T, Scesney SM, Marsh HC, Ryan US, Dalmasso AP, Hancock WW, Bach FH.
    Transplantation; 1996 Aug 15; 62(3):336-42. PubMed ID: 8779679
    [Abstract] [Full Text] [Related]

  • 20. The effect of soluble complement receptor type 1 on acute humoral xenograft rejection in hDAF-transgenic pig-to-primate life-supporting kidney xenografts.
    Lam TT, Hausen B, Hook L, Lau M, Higgins J, Christians U, Jacobsen W, Baluom M, Duthaler R, Katopodis A, Chavez G, Cozzi E, Harrison R, Schuurman HJ, Borie D, Morris RE.
    Xenotransplantation; 2005 Jan 15; 12(1):20-9. PubMed ID: 15598270
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.